On 17 September, Leadsynbio participated simultaneously in Vitafoods Asia 2025 in Bangkok, Thailand, and WPE&WHPE 2025 in Xi’an, China, presenting its flagship synthetic biology-based products and forward-looking solutions. Both exhibitions attracted a broad audience of buyers, experts, and partners, offering a dynamic platform for exchanges and collaboration.

At these two events, Leadsynbio showcased its leading human nutrition portfolio, with a particular focus on the NMN and NAD nicotinamide nucleotide series. Backed by technological breakthroughs and end-to-end supply chain strengths, the company has achieved large-scale production and reliable delivery of anti-aging ingredients such as NMN and NAD. 

To meet evolving market needs, Leadsynbio has also expanded into a broad pipeline of offerings addressing areas such as healthy aging, mood support, weight management, and eye health—aiming to provide global customers with bio-manufactured ingredients that are both sustainable and cost-effective.